IMAGE: In this photo provided ​by The National Institute of Allergy and Infectious Diseases shows a healthy volunteer receiving the NIAID Zika virus investigational DNA vaccine as part of an early-stage trial to test the vaccine's safety and immunogenicity. This is the first administration of this vaccine in a human. (​The National Institute of Allergy and Infectious Diseases via AP)